migalastat has been researched along with Acid beta-Glucosidase Deficiency in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baris, H; Cohen, IJ; Mistry, PK; Sands, MS | 1 |
| Kolter, T; Wendeler, M | 1 |
| Brady, RO | 1 |
| Butters, TD; Dwek, RA; Karlsson, GB; Neises, GR; Platt, FM | 1 |
2 review(s) available for migalastat and Acid beta-Glucosidase Deficiency
| Article | Year |
|---|---|
Chemical chaperones--a new concept in drug research.
Topics: 1-Deoxynojirimycin; alpha-Galactosidase; Animals; Enzyme Stability; Fabry Disease; Galactose; Gaucher Disease; Glycoside Hydrolases; Humans; Imino Sugars; Molecular Weight; Piperidines; Protein Conformation; Protein Folding | 2003 |
Emerging strategies for the treatment of hereditary metabolic storage disorders.
Topics: 1-Deoxynojirimycin; Bone Marrow Transplantation; Enzyme Inhibitors; Fabry Disease; Gangliosidosis, GM1; Gaucher Disease; Genetic Therapy; Humans; Imino Sugars; Piperidines | 2006 |
2 other study(ies) available for migalastat and Acid beta-Glucosidase Deficiency
| Article | Year |
|---|---|
Overcoming the Next Barriers to Successful Therapy.
Topics: 1-Deoxynojirimycin; Administration, Oral; Cellulose; Daucus carota; Drug Delivery Systems; Drug Discovery; Enzyme Inhibitors; Enzyme Replacement Therapy; Fabry Disease; Gaucher Disease; Humans; Lysosomal Storage Diseases; Mucolipidoses; Pyrrolidines; Rare Diseases | 2016 |
N-butyldeoxygalactonojirimycin inhibits glycolipid biosynthesis but does not affect N-linked oligosaccharide processing.
Topics: 1-Deoxynojirimycin; alpha-Glucosidases; Animals; Cells, Cultured; Disease Models, Animal; Gaucher Disease; Glucosylceramidase; Glucosyltransferases; Glycolipids; Humans; Mice; Oligosaccharides; Structure-Activity Relationship | 1994 |